Patents Assigned to Graybug Visioon, Inc.
  • Compounds and compositions for the treatment of ocular disorders
    Patent number: 10159747
    Abstract: The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: December 25, 2018
    Assignee: Graybug Visioon, Inc.
    Inventors: Jeffrey L. Cleland, Ming Yang, John G. Bauman, Nu Hoang, Emmett Cunningham